Is Subclinical Thyroid Dysfunction Associated With with Coronary Heart Disease?

Document Type: Original Article

Authors

1 Internal Medicine, Department of Endocrinology, University of Medical Sciences, Mashhad, Iran.

2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Introduction: Previous cohort studies reported contradictory data on the association between subclinical thyroid dysfunction and coronary heart disease (CHD). Regarding this, the present study was conducted to illuminate this relationship.
Materials and Methods: For the purpose of the study, 3,066 participants employed in a study conducted by Azizi et al. aged ≥ 20 years were subjected to thyroid function tests every 3 years over a mean follow-up of 10 years. After the exclusion of the subjects with CHD and those consumed thyroid, anti-thyroid, or corticosteroid preparations, 2,144 subjects remained for analysis and followed up for CHD events in the next 10 years.
Results: At the baseline, 1929, 139, and 76 subjects had euthyroid, subclinical hyperthyroid, and subclinical hypothyroid, respectively. No CHD event occurred in the subclinical hypothyroid group. After the adjustment of all confounders, the subclinical hyperthyroid group had the hazard ratio of 1.01 for CHD with a 95% confidence interval of 0.36-2.85.
Conclusions: The 10 year follow-up of subjects with subclinical thyroid disease revealed no relationship between CHD and subclinical thyroid disorders.

Keywords


  1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34. PMID 10695693
2.      Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386-8.PMID 4026469
3.      Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community:theWhickhamsurvey.ClinEndocrinol (Oxf)1977; 7: 481-93.PMID 598014
4.      Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA,et al. Serum TSH, T(4), and thyroid antibodies in the United Statespopulation (1988 to 1994): National Health and Nutrition Examination Survey(NHANES III). J ClinEndocrinolMetab 2002; 87: 489-99.PMID 11836274
5.      World Health Organization, World Health Report 1997: Conquering Suffering, Enriching Humanity. Geneva, Switzerland, WHO, 1997. P39
6.      Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.PMID 21160056
7.      Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J ClinEndocrinolMetab 2000; 85: 2993-3001.PMID 10999775
8.      Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factorfor atrial fibrillation in older persons. N Engl J Med 1994;331(19):1249-52.PMID 7935681
9.      Bell GM, Sawers JS, Forfar JC, Doig A, Toft AD. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion.ClinEndocrinol (Oxf) 1983; 18: 511-6.PMID 6409460
10.  Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, SaccàL,etal.Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J ClinEndocrinolMetab 2000; 85: 4701-5.PMID 1113413
11.  Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, CittadiniA,etal.Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J ClinEndocrinolMetab 1999;84(6):2064-7.PMID 8936662
12.  Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL,et al Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006 ;295(9):1033-41.PMID 16507804
13.  Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, othercardiovascular events, and death. Arch Intern Med 2005; 165(21):2460-6.PMID 16314541
14.  Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. ClinEndocrinol (Oxf) 2010;72: 404-10.PMID 19486022
15.  Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels andrisk of fatal coronary heart disease: the HUNT study. Arch Intern Med 2008; 168: 855-60.PMID 18443261
16.  Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, MarianiF,etal.Association between increased mortality and mild thyroid dysfunctionin cardiac patients. Arch Intern Med 2007; 167: 1526-32.PMID 17646607
17.  Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J ClinEndocrinolMetab 2010; 95: 1734-40.PMID 20150579
18.  Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. ClinEndocrinol (Oxf) 1995; 43: 55-68. PMID 7641412
19.  Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study ofan English community. Thyroid 1996; 6: 155-60.PMID 8837320
20.  Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction as a risk factor forcardiovascular disease. Arch Intern Med 2005; 165: 2467-72.PMID 16314542
21.  Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M,etal.Risk for ischemic heartdisease and all-cause mortality in subclinical hypothyroidism. J ClinEndocrinolMetab 2004; 89: 3365-70.PMID 15240616
22.  .Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, CornuzJ,etal.Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heartdisease and mortality. Ann Intern Med 2008; 148: 832-45.PMID 18490668
23.  Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP,et al. Subclinical hypothyroidism and therisk of coronary heart disease and mortality. JAMA 2010; 304: 1365-74.PMID 20858880.